Thermo Fisher Scientific (TMO) Shares Outstanding (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Shares Outstanding (Entity) for 18 consecutive years, with $369.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 2.08% year-over-year to $369.7 million; the trailing twelve-month figure through Jun 2026 stood at $369.7 million (down 2.08% YoY), and the FY2025 full-year result was $371.5 million, down 1.53% from the prior year.
• Shares Outstanding (Entity) declined to $369.7 million in Q2 2026 per TMO's latest filing, from $371.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $392.2 million in Q4 2022 and bottomed at $369.7 million in Q2 2026.
• Historically, Shares Outstanding (Entity) has averaged $381.5 million across 5 years, with a median of $381.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) slipped 0.4% in 2022, then declined 2.08% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $385.4 million in 2022, then declined by 1.07% to $381.3 million in 2023, then decreased by 1.06% to $377.3 million in 2024, then declined by 1.53% to $371.5 million in 2025, then retreated by 0.47% to $369.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $369.7 million, $371.6 million, and $371.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.